CD8A and neoplasm: Moreover, studies have shown that metformin can affect the immune microenvironment of tumor and increase the activity and infiltration of CD8 + cytotoxic T lymphocytes and the production of immune cytokines (49, 50), which implied that the OXPHOS inhibitor can be combined with immune checkpoint inhibitors.